Overview

MRI Iron Oxide Imaging for Lymph Node Staging in Esophageal Cancer

Status:
Withdrawn

Trial end date:
2016-05-01

Target enrollment:

Participant gender:

Summary

This research study is evaluating a new imaging method using MRI (magnetic resonance imaging) to evaluate lymph nodes for evidence of tumor spread from esophageal cancer. This MRI study involves an intravenous contrast called Ferumoxytol (FerahemeTM).

Phase:

Phase 1

Details

Lead Sponsor:

Dana-Farber Cancer Institute

Collaborator:

AMAG Pharmaceuticals, Inc.

Treatments:

Ferrosoferric Oxide